Expression of vascular endothelial growth factor and the effects on bone remodeling during experimental tooth movement

Journal of Dental Research

Volumn 82, Issue 3, 2003, Pages 177-182

  Kohno, S ^a   Kaku, M ^a   Tsutsui, K ^a   Motokawa, M ^a   Ohtani, J ^a   Tenjo, K ^a   Tohma, Y ^a   Tokimasa, C ^a   Fujita, T ^a   Kawata, T ^a   Tanne, K ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Bone remodeling; Experimental tooth movement; Osteoblast; Osteoclast; VEGF

Indexed keywords

COLONY STIMULATING FACTOR 1; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; RECOMBINANT PROTEIN; SIGNAL PEPTIDE; VASCULOTROPIN; VASCULOTROPIN A;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BIOSYNTHESIS; BONE REMODELING; C57BL MOUSE; DRUG EFFECT; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MECHANICAL STRESS; METABOLISM; MOUSE; NONPARAMETRIC TEST; OSTEOBLAST; OSTEOCLAST; PERIODONTAL DISEASE; PHYSIOLOGY;

ANALYSIS OF VARIANCE; ANIMALS; BONE REMODELING; ENDOTHELIAL GROWTH FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, INBRED C57BL; OSTEOBLASTS; OSTEOCLASTS; RECOMBINANT PROTEINS; STATISTICS, NONPARAMETRIC; STRESS, MECHANICAL; TOOTH MOVEMENT; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 18844477211     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910308200306     Document Type: Article

References (27)

1. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D (1996). Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87:3336-3343.
2. Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR (1992). Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3:211-220.
3. Clauss M, Weich H, Breier G, Knies U, Röckl W, Waltenberger J, et al. (1996). The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 271:17629-17634.
4. Collins MK, Sinclair PM (1988). The local use of vitamin D to increase the rate of orthodontic tooth movement. Am J Orthod Dentofacial Orthop 94:278-284.
5. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT (1992). The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991.
6. Dumont DJ, Fong GH, Puri MC, Gradwohl G, Alitalo K, Breitman ML (1995). Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev Dyn 203:80-92.
7. Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR (1995). Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 107:233-235.
8. Felix R, Cecchini MG, Fleisch H (1990). Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology 127:2592-2594.
9. Ferrara N, Houck K, Jakeman L, Leung DW (1992). Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18-32.
10. Harada S, Nagy JA, Sullivan KA, Thomas KA, Endo N, Rodan GA, et al. (1994). Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest 93:2490-2496.
11. Hofstetter W, Wetterwald A, Cecchini MC, Felix R, Fleisch H, Mueller C (1992). Detection of transcripts for the receptor for macrophage colony-stimulating factor, c-fms, in murine osteoclasts. Proc Natl Acad Sci USA 89:9637-9641.
12. Kaku M, Niida S, Kawata T, Maeda N, Tanne K (2000). Dose- and time-dependent changes in osteoclast induction after a single injection of vascular endothelial growth factor in osteopetrotic mice. Biomed Res 21:67-72.
13. Kaku M, Kohno S, Kawata T, Fujita I, Tokimasa C, Tsutsui K, et al. (2001). Effects of vascular endothelial growth factor on osteoclast induction during tooth movement in mice. J Dent Res 80:1880-1883.
14. Kodama H, Yamasaki A, Nose M, Niida S, Ohgame Y, Abe M, et al. (1991a). Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J Exp Med 173:269-272.
15. Kodama H, Nose M, Niida S, Yamasaki A (1991b). Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells. J Exp Med 173:1291-1294.
16. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, et al. (1998). Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
17. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309.
18. Millauer B, Wizigmann-Voos S, Schnürch H, Martinez R, Moller NP, Risau W, et al. (1993). High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835-846.
19. Niida S, Kaku M, Amano H, Yoshida H, Kataoka H, Nishikawa S, et al. (1999). Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med 190:293-298.
20. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985.
21. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, et al. (1990). Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5:519-524.
22. Stark TM, Sinclair PM (1987). Effects of pulsed electromagnetic fields on orthodontic tooth movement. Am J Orthod Dentofac Orthop 91:91-104.
23. Takano-Yamamoto T, Kawakami M, Kobayashi Y, Yamashiro T, Sakuda M (1992). The effect of local application of 1,25-dihydroxycholecalciferol on osteoclast numbers in orthodontically treated rats. J Dent Res 71:53-59.
24. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, et al. (1992). Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187:1579-1586.
25. Wiktor-Jedrzejczak W, Urbanowska E, Aukerman SL, Pollard JW, Stanley ER, Ralph P, et al. (1991). Correction by CSF-1 of defects in the osteopetrotic op/op mouse suggests local, developmental, and humoral requirements for this growth factor. Exp Hematol 19:1049-1054.
26. Yamasaki K, Shibata Y, Imai S, Tani Y, Shibasaki Y, Fukuhara T (1984). Clinical application of prostaglandin E1 (PGE1) upon orthodontic tooth movement. Am J Orthod 85:508-518.
27. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, et al. (1998). Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.